Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
Author:
Jang Hyun-Jong1ORCID, Go Jai-Hyang2, Kim Younghoon3ORCID, Lee Sung Hak3ORCID
Affiliation:
1. Department of Physiology, CMC Institute for Basic Medical Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea 2. Department of Pathology, Dankook University College of Medicine, Cheonan 31116, Republic of Korea 3. Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
Abstract
Diagnosing primary liver cancers, particularly hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), is a challenging and labor-intensive process, even for experts, and secondary liver cancers further complicate the diagnosis. Artificial intelligence (AI) offers promising solutions to these diagnostic challenges by facilitating the histopathological classification of tumors using digital whole slide images (WSIs). This study aimed to develop a deep learning model for distinguishing HCC, CC, and metastatic colorectal cancer (mCRC) using histopathological images and to discuss its clinical implications. The WSIs from HCC, CC, and mCRC were used to train the classifiers. For normal/tumor classification, the areas under the curve (AUCs) were 0.989, 0.988, and 0.991 for HCC, CC, and mCRC, respectively. Using proper tumor tissues, the HCC/other cancer type classifier was trained to effectively distinguish HCC from CC and mCRC, with a concatenated AUC of 0.998. Subsequently, the CC/mCRC classifier differentiated CC from mCRC with a concatenated AUC of 0.995. However, testing on an external dataset revealed that the HCC/other cancer type classifier underperformed with an AUC of 0.745. After combining the original training datasets with external datasets and retraining, the classification drastically improved, all achieving AUCs of 1.000. Although these results are promising and offer crucial insights into liver cancer, further research is required for model refinement and validation.
Funder
National Research Foundation of Korea
Subject
Cancer Research,Oncology
Reference50 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021 2. Torbenson, M., Ng, I., Park, Y., Roncalli, M., and Sakamato, M. (2019). WHO Classification of Tumours. Digestive System Tumours, International Agency for Research on Cancer. 3. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma;Mak;Am. Soc. Clin. Oncol. Educ. Book,2018 4. Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images;Cooper;Lab. Investig.,2015 5. Chen, C., Chen, C., Ma, M., Ma, X., Lv, X., Dong, X., Yan, Z., Zhu, M., and Chen, J. (2022). Classification of multi-differentiated liver cancer pathological images based on deep learning attention mechanism. BMC Med. Inform. Decis. Mak., 22.
|
|